Enlie Pharmaceutical JSC

Enlie Pharmaceutical JSC FCF per Share

The Free Cash Flow per Share of Enlie Pharmaceutical JSC (BCP.VN) as of Oct 23, 2026 is 159.27 VND. In the previous year, Free Cash Flow per Share was 1,114.41 VND — a change of -85.71% (lower).

FCF per Share

159.27VND

YoY

-85.71%

Last updated:

Free Cash Flow per Share of Enlie Pharmaceutical JSC is 2024 159.27 VND. Free Cash Flow per Share of Enlie Pharmaceutical JSC was 2023 1,114.41 VND. It decreases by -85.71% lower compared to the previous year.

The Enlie Pharmaceutical JSC FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
5,564.25 VND
Jan 1, 2018
1,376.40 VND
Jan 1, 2019
1,234.33 VND
Jan 1, 2020
-1,987.50 VND
Jan 1, 2021
-4,004.67 VND
Jan 1, 2022
-2,850.48 VND
Jan 1, 2023
1,114.41 VND
Jan 1, 2024
159.27 VND
The Enlie Pharmaceutical JSC FCF per Share history
YEARFCF per ShareYoY
159.27VND-85.71%
1,114.41VND-139.10%
-2,850.48VND-28.82%
-4,004.67VND+101.49%
-1,987.50VND-261.02%
1,234.33VND-10.32%
1,376.40VND-75.26%
5,564.25VND-447.39%
-1,601.75VND-219.31%
1,342.50VND-281.54%
-739.50VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Enlie Pharmaceutical JSC Stock analysis

What does Enlie Pharmaceutical JSC do? Enlie Pharmaceutical JSC generates revenue primarily through the manufacture and commerce of pharmaceutical preparations, medical equipment, and health supplements. The company leverages its core expertise in these healthcare categories to serve the market, establishing its primary income streams around the production and sale of these essential health products. In addition to its pharmaceutical operations, the firm has diversified its business model by expanding into the real estate industry. This segment involves the development of various commercial and residential infrastructures which are then made available for lease, providing an additional layer of financial activity beyond its core healthcare focus. Enlie Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enlie Pharmaceutical JSC stock

Free Cash Flow per Share of Enlie Pharmaceutical JSC is 159.27 VND in 2024.

Free Cash Flow per Share of Enlie Pharmaceutical JSC changed from 1,114.41 VND to 159.27 VND, representing a -85.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Enlie Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Enlie Pharmaceutical JSC

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Enlie Pharmaceutical JSC